Ocera Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 23   

Articles published

OCRX 5.84 0.00 (0.00%)
price chart
Ocera Therapeutics to Announce Second Quarter Financial Results
PALO ALTO, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that it will release its second quarter financial ...
Related articles »  
Ocera Therapeutics Inc.: Ocera Reports Second Quarter 2014 Financial Results
PALO ALTO, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced its financial results for the second quarter ...
Ocera Reports Second Quarter 2014 Financial Results  MarketWatch
Ocera Therapeutics Price Target Cut to $17.00 by Analysts at Stifel Nicolaus ...  WKRB News
Related articles »  
Stock Runners : Ciena Corporation (NYSE:CIEN), Ocera Therapeutics (NASDAQ ...
On AUG 11, Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, announced that Rajiv Patni, M.D.
Worth Watching Stocks: TrovaGene (NASDAQ:TROV), Ocera Therapeutics ...
For the six months ended June 30, 2014, Trovagene Inc. (NASDAQ:TROV) on 7 August reported a net loss of $4.3 million, or $0.23 per share, as compared to a net loss of $6.4 million, or $0.41 per share, for the six months ended June 30, 2013.
Fast Moving Stocks : General Electric (NYSE:GE), Glu Mobile (NASDAQ:GLUU ...
On 31 July 2014 Ocera Therapeutics (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, announced that it will release its second quarter financial results on August 11, 2014 at approximately ...
Investors Are Watching: Digital River Inc. (NASDAQ:DRIV), Jazz ...
On 11 AUG Ocera Therapeutics, Inc. (NASDAQ:OCRX) posted its quarterly earnings results on Monday. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.45) by $0.01.
Investors Alert: Walgreen Co. (NYSE:WAG), BlackBerry Ltd (NASDAQ:BBRY ...
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, on 11 August announced its financial results for the second quarter ended June 30, 2014.
Related articles »  
Trader's Watch List: The Western Union Company (NYSE:WU), Digital Ally Inc ...
Following the acquisition, the chief executive officer now directly owns 10,000 shares of the company's stock, valued at approximately $59,300.
Hot Stocks: Borderfree (NASDAQ:BRDR), General Electric Company (NYSE:GE ...
Following the acquisition, the chief executive officer now directly owns 10,000 shares of the company's stock, valued at approximately $59,300.
Related articles »  
Hot News : SemiLEDs Corporation (NASDAQ:LEDS), AbbVie Inc. (NYSE:ABBV ...
Its return on assets (ROA) is 0.30% while return on investment (ROI) is 30.70%. CenterState Banks, Inc. (NASDAQ:CSFL) price to earnings (P/E) ratio is 37.21.